Biotechnology and the pharmaceutical industry. New cardiovascular drugs.
نویسندگان
چکیده
منابع مشابه
Drugs obtained by biotechnology processing
In recent years, the number of drugs of biotechnological origin available for many different diseases has increased exponentially, including different types of cancer, diabetes mellitus, infectious diseases (e.g. AIDS Virus / HIV) as well as cardiovascular, neurological, respiratory, and autoimmune diseases, among others. The pharmaceutical industry has used different technologies to obtain new...
متن کاملWhat is a Biopharmaceutical ?
T he terms biotechnology and biopharmaceutical describe many complex and important products, technologies, R&D, and industries. Most people, particularly those within the industry, presume that a biopharmaceutical involves biotechnology, but this connection is often ignored or rejected. That causes problems in communication and public perception. This article examines biopharmaceutical terminol...
متن کاملPerspective of the Future of Pharmaceutical Technology in Iran
Pharmaceutical industry is currently undergoing a transient phase with new orientation. Loss of financial resources, presence of new therapeutic agents and increasing cost of research and development have called for a full.scale restructuring within the pharmaceutical industry to retain even the most basic competitiveness. The development of new technologies has been as one way out of the dile...
متن کاملFour scenarios for the future of the pharmaceutical industry
Pharmaceutical companies are facing several major interrelated challenges, the most strategic being the decline in R&D productivity resulting in empty product pipelines to replace products nearing patent expiry. A common response has been mergers and acquisition of competitors and biotechnology firms, but rather than resolving the problems, this has created new ones. While biotechnology promise...
متن کاملPerspective of the Future of Pharmaceutical Technology in Iran
Pharmaceutical industry is currently undergoing a transient phase with new orientation. Loss of financial resources, presence of new therapeutic agents and increasing cost of research and development have called for a full.scale restructuring within the pharmaceutical industry to retain even the most basic competitiveness. The development of new technologies has been as one way out of the dile...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Hypertension
دوره 8 11 شماره
صفحات -
تاریخ انتشار 1986